| Dr Wesley B Roney, MD | |
|
2501 N Patterson St, Valdosta, GA 31602-1735 | |
| (229) 443-1000 | |
| (706) 596-6723 |
| Full Name | Dr Wesley B Roney |
|---|---|
| Gender | Male |
| Speciality | Diagnostic Radiology |
| Experience | 31 Years |
| Location | 2501 N Patterson St, Valdosta, Georgia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1427008549 | NPI | - | NPPES |
| 64325939 | Medicaid | KY | |
| 003207222A-I | Medicaid | GA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0202X | Radiology - Diagnostic Radiology | 79973 (Georgia) | Secondary |
| 2085R0202X | Radiology - Diagnostic Radiology | 32593 (Kentucky) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| South Georgia Medical Center | Valdosta, GA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Radiology Associates Of Valdosta Llc | 5294914198 | 6 |
News Archive
In a world first, Dr. Andres M. Lozano and his team at Toronto Western Hospital has shown using Deep Brain Stimulation (DBS) on patients with early signs of Alzheimer's disease is safe and may help improve memory. The phase one safety trial of six Ontario patients took place from 2005 to 2008. All patients left hospital within 2 to 3 days of surgery, and continue to participate in regular follow-up cognitive assessments.
Incyte Corporation today announced that its strategic collaborator, Novartis, received approval from the European Commission for Jakavi (INC424, ruxolitinib), an oral JAK 1 and JAK 2 inhibitor discovered by Incyte, for the treatment of disease-related splenomegaly or symptoms in adult patients with primary myelofibrosis (also known as chronic idiopathic myelofibrosis), post-polycythemia vera myelofibrosis or post-essential thrombocythemia myelofibrosis.
Whether their effectiveness is fact or fiction, less invasive cosmetic procedures such as cleavage rejuvenation, do-it-yourself (DIY) cosmetic therapies, and using Botox- to "lift" the breasts are making headlines, but are they safe? Plastic surgeons will discuss if these, and more, are cutting edge new discoveries or just "buyer beware" marketing hype at the American Society of Plastic Surgeons (ASPS) Plastic Surgery 2009 conference, Oct. 23 - 27, in Seattle.
Scientific theory holds that Huntington's disease (HD) is caused by a mutant protein that arises within brain cells and kills them, triggering the genetic neurological disorder. Now a new UCLA Neuropsychiatric Institute study reveals the first strong evidence that the mutant protein also elicits toxic interactions from neighboring cells to provoke the fatal brain disorder. The May 5 edition of Neuron reports the findings.
› Verified 7 days ago
| Entity Name | Radiology Associates Of Valdosta Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1134429582 PECOS PAC ID: 5294914198 Enrollment ID: O20110125000262 |
News Archive
In a world first, Dr. Andres M. Lozano and his team at Toronto Western Hospital has shown using Deep Brain Stimulation (DBS) on patients with early signs of Alzheimer's disease is safe and may help improve memory. The phase one safety trial of six Ontario patients took place from 2005 to 2008. All patients left hospital within 2 to 3 days of surgery, and continue to participate in regular follow-up cognitive assessments.
Incyte Corporation today announced that its strategic collaborator, Novartis, received approval from the European Commission for Jakavi (INC424, ruxolitinib), an oral JAK 1 and JAK 2 inhibitor discovered by Incyte, for the treatment of disease-related splenomegaly or symptoms in adult patients with primary myelofibrosis (also known as chronic idiopathic myelofibrosis), post-polycythemia vera myelofibrosis or post-essential thrombocythemia myelofibrosis.
Whether their effectiveness is fact or fiction, less invasive cosmetic procedures such as cleavage rejuvenation, do-it-yourself (DIY) cosmetic therapies, and using Botox- to "lift" the breasts are making headlines, but are they safe? Plastic surgeons will discuss if these, and more, are cutting edge new discoveries or just "buyer beware" marketing hype at the American Society of Plastic Surgeons (ASPS) Plastic Surgery 2009 conference, Oct. 23 - 27, in Seattle.
Scientific theory holds that Huntington's disease (HD) is caused by a mutant protein that arises within brain cells and kills them, triggering the genetic neurological disorder. Now a new UCLA Neuropsychiatric Institute study reveals the first strong evidence that the mutant protein also elicits toxic interactions from neighboring cells to provoke the fatal brain disorder. The May 5 edition of Neuron reports the findings.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Wesley B Roney, MD Po Box 1524, Columbus, GA 31902-1524 Ph: (800) 841-4236 | Dr Wesley B Roney, MD 2501 N Patterson St, Valdosta, GA 31602-1735 Ph: (229) 443-1000 |
News Archive
In a world first, Dr. Andres M. Lozano and his team at Toronto Western Hospital has shown using Deep Brain Stimulation (DBS) on patients with early signs of Alzheimer's disease is safe and may help improve memory. The phase one safety trial of six Ontario patients took place from 2005 to 2008. All patients left hospital within 2 to 3 days of surgery, and continue to participate in regular follow-up cognitive assessments.
Incyte Corporation today announced that its strategic collaborator, Novartis, received approval from the European Commission for Jakavi (INC424, ruxolitinib), an oral JAK 1 and JAK 2 inhibitor discovered by Incyte, for the treatment of disease-related splenomegaly or symptoms in adult patients with primary myelofibrosis (also known as chronic idiopathic myelofibrosis), post-polycythemia vera myelofibrosis or post-essential thrombocythemia myelofibrosis.
Whether their effectiveness is fact or fiction, less invasive cosmetic procedures such as cleavage rejuvenation, do-it-yourself (DIY) cosmetic therapies, and using Botox- to "lift" the breasts are making headlines, but are they safe? Plastic surgeons will discuss if these, and more, are cutting edge new discoveries or just "buyer beware" marketing hype at the American Society of Plastic Surgeons (ASPS) Plastic Surgery 2009 conference, Oct. 23 - 27, in Seattle.
Scientific theory holds that Huntington's disease (HD) is caused by a mutant protein that arises within brain cells and kills them, triggering the genetic neurological disorder. Now a new UCLA Neuropsychiatric Institute study reveals the first strong evidence that the mutant protein also elicits toxic interactions from neighboring cells to provoke the fatal brain disorder. The May 5 edition of Neuron reports the findings.
› Verified 7 days ago
Dr. Robert Harold Wise Jr., M.D. Radiology Medicare: Not Enrolled in Medicare Practice Location: 2704 N Oak St, Building E, Valdosta, GA 31602 Phone: 229-333-9729 Fax: 229-333-0832 | |
Dr. Thomas M Lott Jr., M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 2501 N Patterson St, Valdosta, GA 31602 Phone: 229-433-1000 Fax: 706-596-6723 | |
Dr. William Michael Querin, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 2704 N Oak St, Building E, Valdosta, GA 31602 Phone: 229-333-9729 Fax: 229-333-0832 | |
Dr. Michael R Millner, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 2501 N Patterson St, Valdosta, GA 31602 Phone: 229-259-4888 Fax: 229-559-8178 | |
Dr. Richard Glynn Cooper, M.D. Radiology Medicare: Not Enrolled in Medicare Practice Location: 2704 N Oak St, Building E, Valdosta, GA 31602 Phone: 229-333-9729 Fax: 229-333-0832 | |
Daniel P Moloney, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 2501 N Patterson St, Valdosta, GA 31602 Phone: 229-433-1000 Fax: 706-596-6723 |